Role of copper and cholesterol association in the neurodegenerative process

International Journal of Alzheimer's Disease

Volumn 2013, Issue , 2013, Pages

  Arnal, Nathalie ^a   Morel, Gustavo R ^a   De Alaniz, María J T ^a   Castillo, Omar ^b   Marra, Carlos A ^a  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CALPAIN; CASPASE 3; CHOLESTEROL; COPPER; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; NITRATE; NITRITE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; COPPER BLOOD LEVEL; ESTERIFICATION; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; LATENT PERIOD; LIPID PEROXIDATION; MALE; MEMORY; NERVE DEGENERATION; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

EID: 84888611842     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2013/414817     Document Type: Article

References (99)

1. Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A., Evans D. A., Alzheimer disease in the US population: prevalence estimates using the 2000 census. Archives of Neurology 2003 60 8 1119 1122 2-s2.0-0042023711 10.1001/archneur.60.8.1119 (Pubitemid 36975801)
2. Bagnati P. M., Allegri R. F., Kremer J., Taragano F. E., Enfermedad de Alzheimer y Otras Demencias 2010 Ed. Polemos
3. Brewer G. J., Issues raised involving the copper hypotheses in the causation of Alzheimer's disease. International Journal of Alzheimer's Disease 2011 2011 11 2-s2.0-81555207176 10.4061/2011/537528 537528
4. Foster H. D., Why the preeminent risk factor in sporadic Alzheimer's disease cannot be genetic. Medical Hypotheses 2002 59 1 57 61 2-s2.0-0036655937 10.1016/S0306-9877(02)00116-0
5. Salustri C., Barbati G., Ghidoni R., Quintiliani L., Ciappina S., Binetti G., Squitti R., Is cognitive function linked to serum free copper levels? A cohort study in a normal population. Clinical Neurophysiology 2010 121 4 502 507 2-s2.0-77649182895 10.1016/j.clinph.2009.11.090
6. Brewer G. J., Copper toxicity in Alzheimer's disease: cognitive loss from ingestion of inorganic copper. Journal of Trace Elements in Medicine and Biology 2012 26 2-3 89 92 10.1016/j.jtemb.2012.04.019
7. Squitti R., Ghidoni R., Scrascia F., Benussi L., Panetta V., Pasqualetti P., Moffa F., Bernardini S., Ventriglia M., Binetti G., Rossini P. M., Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals. Journal of Alzheimer's Disease 2011 23 2 239 248 2-s2.0-79951563119 10.3233/JAD-2010-101098
8. Squitti R., Pasqualetti P., dal Forno G., Moffa F., Cassetta E., Lupoi D., Vernieri F., Rossi L., Baldassini M., Rossini P. M., Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 2005 64 6 1040 1046 2-s2.0-20144371701 (Pubitemid 40388458)
9. Squitti R., Barbati G., Rossi L., Ventriglia M., Dal Forno G., Cesaretti S., Moffa F., Caridi I., Cassetta E., Pasqualetti P., Calabrese L., Lupoi D., Rossini P. M., Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β -amyloid, and h-tau. Neurology 2006 67 1 76 82 2-s2.0-33746792029 10.1212/01.wnl.0000223343.82809.cf (Pubitemid 44305465)
10. Squitti R., Bressi F., Pasqualetti P., Bonomini C., Ghidoni R., Binetti G., Cassetta E., Moffa F., Ventriglia M., Vernieri F., Rossini P. M., Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease. Neurology 2009 72 1 50 55 2-s2.0-63849241137 10.1212/01.wnl.0000338568.28960.3f
11. Arnal N., Cristalli D. O., de Alaniz M. J. T., Marra C. A., Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Research 2010 1319 118 130 2-s2.0-77049115153 10.1016/j.brainres.2009.11.085
12. Sparks D. L., Schreurs B. G., Trace amounts of copper in water induce β -amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2003 100 19 11065 11069 2-s2.0-0141702360 10.1073/pnas.1832769100 (Pubitemid 37140153)
13. Lu J., Zheng Y.-L., Wu D.-M., Sun D.-X., Shan Q., Fan S.-H., Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis. FEBS Letters 2006 580 28-29 6730 6740 2-s2.0-36148943585 10.1016/j.febslet.2006.10.072 (Pubitemid 44827008)
14. Lu J., Wu D.-M., Zheng Y.-L., Sun D.-X., Hu B., Shan Q., Zhang Z.-F., Fan S.-H., Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Brain, Behavior, and Immunity 2009 23 2 193 203 2-s2.0-58549116872 10.1016/j.bbi.2008. 09.003
15. Donnelly P. S., Xiao Z., Wedd A. G., Copper and Alzheimer's disease. Current Opinion in Chemical Biology 2007 11 128 133 (Pubitemid 46546475)
16. Cockell K. A., Bertinato J., L'Abbé M. R., Regulatory frameworks for copper considering chronic exposures of the population. American Journal of Clinical Nutrition 2008 88 3 863S 866S 2-s2.0-51749122676
17. Arnal N., de Alaniz M. J. T., Marra C. A., Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380A. Toxicology Letters 2010 192 3 373 378 2-s2.0-75549087496 10.1016/j.toxlet.2009.11.012
18. Arnal N., Astiz M., de Alaniz M. J. T., Marra C. A., Clinical parameters and biomarkers of oxidative stress in agricultural workers who applied copper-based pesticides. Ecotoxicology and Environmental Safety 2011 74 6 1779 1786 2-s2.0-79961125901 10.1016/j.ecoenv.2011.05.018
19. de la Cruz D., Cruz A., Arteaga M., Castillo L., Tovalin H., Blood copper levels in Mexican users of the T380A IUD. Contraception 2005 72 2 122 125 2-s2.0-22044448338 10.1016/j.contraception.2005.02.009 (Pubitemid 40966983)
20. Grant W. B., Dietary links to Alzheimer's disease. Alzheimer's Disease Review 1997 2 42 55
21. Pappolla M. A., Smith M. A., Bryant-Thomas T., Bazan N., Petanceska S., Perry G., Thal L. J., Sano M., Refolo L. M., Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radical Biology & Medicine 2002 33 2 173 181 2-s2.0-0037098872 10.1016/S0891- 5849(02)00841-9 (Pubitemid 34775189)
22. Di Paolo G., Kim T.-W., Linking lipids to Alzheimer's disease: cholesterol and beyond. Nature Reviews Neuroscience 2011 12 5 284 296 2-s2.0-79955051063 10.1038/nrn3012
23. Stefani M., Liguri G., Colesterol in Alzheimer's disease: unresolved questions. Current Alzheimer Research 2009 6 1 17
24. Schreurs B., The effects of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews 2010 34 8 1366 1379 10.1016/j.neubiorev.2010.04.010
25. Morris M. C., Evans D. A., Tangney C. C., Bienias J. L., Schneider J. A., Wilson R. S., Scherr P. A., Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Archives of Neurology 2006 63 8 1085 1088 2-s2.0-33747204555 10.1001/archneur.63.8.1085 (Pubitemid 44232313)
26. Reeves P. G., Nielsen F. H., Fahey G. C. Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Journal of Nutrition 1993 123 11 1939 1951 2-s2.0-0027487229 (Pubitemid 23342492)
27. National Institute of Health, Guide for the Care and Use of Laboratory Animals 1985 Bethesda, Md, USA National Research Council NIH Publication no. 85-23
28. Cockell K. A., Wotherspoon A. T. L., Belonje B., Fritz M. E., Madère R., Hidiroglou N., Plouffe L. J., Ratnayake W. M. N., Kubow S., Limited effects of combined dietary copper deficiency/iron overload on oxidative stress parameters in rat liver and plasma. Journal of Nutritional Biochemistry 2005 16 12 750 756 2-s2.0-27744515259 10.1016/j.jnutbio.2005.04.003 (Pubitemid 41624797)
29. Davis C. D., Newman S., Inadequate dietary copper increases tumorigenesis in the Min mouse. Cancer Letters 2000 159 1 57 62 2-s2.0-0034676248 10.1016/S0304-3835(00)00531-0
30. Paxinos G., Watson C., The Rat Brain in Stereotaxic Coordinates 1998 4th Boston, Mass, USA Academic Press
31. Berkovitch M., Heyman E., Afriat R., Matz-Khromchenko I., Avgil M., Greenberg R., Zimmerman D. R., Berman S., Weissgarten J., Copper and zinc blood levels among children with nonorganic failure to thrive. Clinical Nutrition 2003 22 2 183 186 2-s2.0-0037378628 10.1054/clnu.2002.0619 (Pubitemid 36372463)
32. Terrés-Martos C., Navarro-Alarcón M., Martín-Lagos F., López-G de la Serrana H., López-Martínez M. C., Determination of copper levels in serum of healthy subjects by atomic absorption spectrometry. Science of The Total Environment 1997 198 1 97 103 10.1016/S0048-9697(97)05448-X (Pubitemid 27204835)
33. Martínez-Subiela S., Tecles F., Ceron J. J., Comparison of two automated spectrophotometric methods for ceruloplasmin measurement in pigs. Research in Veterinary Science 2007 83 1 12 19 2-s2.0-34247543389 10.1016/j.rvsc.2006.10.011 (Pubitemid 46648009)
34. Twomey P. J., Wierzbicki A. S., Hose I. M., Viljoen A., Reynolds T. M., Percentage non-ceruloplasmin bound copper. Clinical Biochemistry 2007 40 9-10 749 750 10.1016/j.clinbiochem.2007.04.002 (Pubitemid 46829085)
35. Folch J., Lees M., Sloane Stanley G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
36. Marra C. A., De Alaniz M. J. T., Neutral and polar lipid metabolism in liver microsomes of growing rats fed a calcium-deficient diet. Biochimica et Biophysica Acta 2005 1686 3 220 237 2-s2.0-11144310101 10.1016/j.bbalip.2004.10. 003 (Pubitemid 40039149)
37. Yagi K., A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 1976 15 2 212 216 2-s2.0-0017065248
38. Miranda K. M., Espey M. G., Wink D. A., A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001 5 1 62 71 2-s2.0-0035709008 10.1006/niox.2000.0319 (Pubitemid 34146173)
39. Reznick A. Z., Packer L., Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods in Enzymology 1994 233 357 363 2-s2.0-0028239163 10.1016/S0076-6879(94)33041-7
40. Anderson M. E., Meister A., Enzymic assay of GSSG plus GSH. Methods in Enzymology 1984 105 448 450
41. Buttriss J. L., Diplock A. T., High-performance liquid chromatography methods for vitamin E in tissues. Methods in Enzymology 1984 105 131 138 2-s2.0-0021288820 (Pubitemid 14165380)
42. Bagnati M., Bordone R., Perugini C., Cau C., Albano E., Bellomo G., Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation. Biochemical and Biophysical Research Communications 1998 253 2 235 240 2-s2.0-0032545396 10.1006/bbrc.1998.9777 (Pubitemid 29026687)
43. Carlberg I., Mannervik B., Glutathione reductase. Methods in Enzymology 1985 113 484 490 2-s2.0-0022272480 (Pubitemid 16195819)
44. Botha N., Gehringer M. M., Downing T. G., van de Venter M., Shephard E. G., The role of microcystin-LR in the induction of apoptosis and oxidative stress in CaCo2 cells. Toxicon 2004 43 1 85 92 2-s2.0-1242314785 10.1016/j.toxicon.2003.10.025 (Pubitemid 38230878)
45. Zana M., Janka Z., Kálmán J., Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. Neurobiology of Aging 2007 28 5 648 676 (Pubitemid 46349350)
46. Praticò D., Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends in Pharmacological Sciences 2008 29 12 609 615 10.1016/j.tips.2008.09.001
47. Song F., Poljak A., Smythe G. A., Sachdev P., Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Research Reviews 2009 61 2 69 80 2-s2.0-70349499185 10.1016/j.brainresrev.2009.05.003
48. Mangialasche F., Polidori M. C., Monastero R., Ercolani S., Camarda C., Cecchetti R., Mecocci P., Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Research Reviews 2009 8 4 285 305 2-s2.0-69049109744 10.1016/j.arr.2009.04.002
49. Skoumalová A., Hort J., Blood markers of oxidative stress in Alzheimer's disease. Journal of Cellular and Molecular Medicine 2012 16 2291 2300
50. Kosenko E. A., Aliev G., Tikhonova L. A., Li Y., Poghosyan A. C., Kaminsky Y. G., Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. CNS & Neurological Disorders-Drug Targets 2012 11 7 926 932 10.2174/1871527311201070926
51. López N., Tormo C., De Blas I., Llinares I., Alom J., Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. Journal of Alzheimer's Disease 2013 33 823 829
52. Badía M. C., Giraldo E., Dasí F., Reductive stress in young healthy individuals at risk of Alzheimer disease. Free Radical Biology & Medicine 2013 63 274 279 10.1016/j.freeradbiomed.2013.05.003
53. Campbell A., Smith M. A., Sayre L. M., Bondy S. C., Perry G., Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Research Bulletin 2001 55 2 125 132 2-s2.0-0035872474 10.1016/S0361-9230(01) 00455-5 (Pubitemid 32722152)
54. Rossi L., Squitti R., Calabrese L., Rotilio G., Rossini P. M., Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy. Journal of Nutrition, Health and Aging 2007 11 5 408 417 2-s2.0-38349084395
55. Viles J. H., Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases. Coordination Chemistry Reviews 2012 256 19-20 2271 2284 10.1016/j.ccr.2012.05. 003
56. Squitti R., Metals in alzheimer's disease: a systemic perspective. Frontiers in Bioscience 2012 17 2 451 472 2-s2.0-84858982731 10.2741/3938
57. Kojima S., Matsuki O., Nomura T., Shimura N., Kubodera A., Yamaoka K., Tanooka H., Wakasugi H., Honda Y., Honda S., Sasaki T., Localization of glutathione and induction of glutathione synthesis- related proteins in mouse brain by low doses of γ -rays. Brain Research 1998 808 2 262 269 2-s2.0-0032547876 10.1016/S0006-8993(98)00832-4 (Pubitemid 29009558)
58. Sharma Y., Bashir S., Irshad M., Nag T. C., Dogra T. D., Dimethoate-induced effects on antioxidant status of liver and brain of rats following subchronic exposure. Toxicology 2005 215 3 173 181 2-s2.0-26844514567 10.1016/j.tox.2005.06.029 (Pubitemid 41446319)
59. Dringen R., Metabolism and functions of glutathione in brain. Progress in Neurobiology 2000 62 6 649 671 2-s2.0-0034672943 10.1016/S0301-0082(99)00060-X (Pubitemid 30407139)
60. Dringen R., Oxidative and antioxidative potential of brain microglial cells. Antioxidants and Redox Signaling 2005 7 9-10 1223 1233 2-s2.0-24144473653 10.1089/ars.2005.7.1223 (Pubitemid 41232519)
61. Pallottini V., Martini C., Bassi A. M., Romano P., Nanni G., Trentalance A., Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. Journal of Hepatology 2006 44 2 368 374 2-s2.0-30344481928 10.1016/j.jhep.2005.06.011 (Pubitemid 43069219)
62. Pfrieger F. W., Ungerer N., Cholesterol metabolism in neurons and astrocytes. Progress in Lipid Research 2011 50 4 357 371 2-s2.0-79960459422 10.1016/j.plipres.2011.06.002
63. Leoni V., Caccia C., Oxysterols as biomarkers in neurodegenerative diseases. Chemistry and Physics of Lipids 2011 164 6 515 524 2-s2.0-80051472136 10.1016/j.chemphyslip.2011.04.002
64. Stefani M., Liguri G., Cholesterol in Alzheimer's disease: unresolved questions. Current Alzheimer Research 2009 6 1 15 29 2-s2.0-58149220667 10.2174/156720509787313899
65. Takeda S., Sato N., Ikimura K., Nishino H., Rakugi H., Morishita R., Increased blood-grain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiology of Aging 2013 34 8 2064 2070 10.1016/j.neurobiolaging.2013.02.010
66. Wang J., Ohno-Matsui K., Morita I., Cholesterol enhances amyloid β deposition in mouse retina by modulating the activities of A β -regulating enzymes in retinal pigment epithelial cells. Biochemical and Biophysical Research Communications 2012 424 4 704 709 10.1016/j.bbrc.2012.07.014
67. Galbete J. L., Rodriguez-Martin T., Peressini E., Modena P., Bianchi R., Forloni G., Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochemical Journal 2000 348 2 307 313 2-s2.0-0034214328 10.1042/0264-6021:3480307 (Pubitemid 30345202)
68. Svensson P. A., Englund M. C., Markström E., Copper induces the expression of cholesterogenic genes in human macrophages. Atherosclerosis 2003 169 1 71 76 10.1016/S0021-9150(03)00145-X (Pubitemid 36830924)
69. Sparks D. L., Ziolkowski C., Lawmaster T., Martin T., Influence of water quality on cholesterol-induced tau pathology: preliminary data. International Journal of Alzheimer's Disease 2011 2011 7 987023 10.4061/2011/987023
70. Jack C. R. Jr., Knopman D. S., Jagust W. J., Shaw L. M., Aisen P. S., Weiner M. W., Petersen R. C., Trojanowski J. Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology 2010 9 1 119 128 2-s2.0-72049130805 10.1016/S1474-4422(09)70299-6
71. Jack C. R. Jr., Lowe V. J., Weigand S. D., Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009 132, part 5 1355 1365 10.1093/brain/awp062
72. Zetterberg H., Blennow k., Hanse E., Amyloid beta and APP as biomarkers for Alzheimer's disease. Experimental Gerontology 2010 45 1 23 29 10.1016/j.exger.2009.08.002
73. Tamaoka A., Fukushima T., Sawamura N., Ishikawa K., Oguni E., Komatsuzaki Y., Shoji S., Amyloid β protein in plasma from patients with sporadic Alzheimer' s disease. Journal of the Neurological Sciences 1996 141 1-2 65 68 2-s2.0-0030587520 10.1016/0022-510X(96)00143-8 (Pubitemid 26297732)
74. Lewczuk P., Kornhuber J., Vanmechelen E., Peters O., Heuser I., Maier W., Jessen F., Bürger K., Hampel H., Frölich L., Henn F., Falkai P., Rüther E., Jahn H., Luckhaus C., Perneczky R., Schmidtke K., Schröder J., Kessler H., Pantel J., Gertz H.-J., Vanderstichele H., de Meyer G., Shapiro F., Wolf S., Bibl M., Wiltfang J., Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing. Experimental Neurology 2010 223 2 366 370 2-s2.0-77952548703 10.1016/j.expneurol.2009.07.024
75. Crouch P. J., Harding S. M., White A. R., Camakaris J., Bush A. I., Masters C. L., Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. The International Journal of Biochemistry & Cell Biology 2008 40 2 181 198 10.1016/j.biocel.2007.07.013 (Pubitemid 350137874)
76. 2 and 4-hydroxynonenal mediate amyloid β -induced neuronal apoptosis by activating JNKs and p38MAPK. Experimental Neurology 2003 180 2 144 155 2-s2.0-0037382957 10.1016/S0014-4886(02)00059-6 (Pubitemid 36398169)
77. Ahn B. R., Moon H. E., Kim H. R., Jung H. A., Choi J. S., Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid betapeptide-induced toxicity in PC12 cells. Archives of Pharmacal Research 2012 35 11 1989 1998
78. Luo T., Jiang W., Kong Y., Li S., He F., Xu J., Wang H. Q., The protective effects of jatrorrhizine on β -amyloid (25-35)-induced neurotoxicity in rat cortical neurons. CNS & Neurological Disorders Drug Targets 2012 11 8 1030 1037
79. 1-40) administration in mice. Behavioural Brain Research 2013 244 107 115 10.1016/j.bbr.2013.01.039
80. Harkany T., Abrahám I., Kónya C., Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy. Reviews in the Neurosciences 2000 11 4 329 382
81. 2 formation with A β 40 conformation. International Journal of Alzheimer's Disease 2011 2011 7 2-s2.0-79952148056 10.4061/2011/607861 607861
82. Paola D., Domenicotti C., Nitti M., Vitali A., Borghi R., Cottalasso D., Zaccheo D., Odetti P., Strocchi P., Marinari U. M., Tabaton M., Pronzato M. A., Oxidative stress induces increase in intracellular amyloid β -protein production and selective activation of β I and β II PKCs in NT2 cells. Biochemical and Biophysical Research Communications 2000 268 2 642 646 2-s2.0-0034673209 10.1006/bbrc.2000.2164 (Pubitemid 30119675)
83. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M. A., Perry G., Tabaton M., β -site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. Journal of Neurochemistry 2005 92 3 628 636 2-s2.0-19944433845 10.1111/j.1471-4159.2004.02895.x (Pubitemid 40189465)
84. Lin C.-J., Huang H.-C., Jiang Z.-F., Cu(II) interaction with amyloid- β peptide: a review of neuroactive mechanisms in AD brains. Brain Research Bulletin 2010 82 5-6 235 242 2-s2.0-77955088624 10.1016/j.brainresbull.2010.06. 003
85. Galasko D., Montine T. J., Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomarkers in Medicine 2010 4 1 27 36 2-s2.0-77951689435 10.2217/bmm.09.89
86. Arnal N., de Alaniz M. J., Marra C. A., Cytotoxic effects of copper overload on human-derived lung and liver cells in culture. Biochimica et Biophysica Acta 2012 1820 7 931 939 10.1016/j.bbagen.2012.03.007
87. Saito K.-I., Elce J. S., Hamos J. E., Nixon R. A., Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America 1993 90 7 2628 2632 2-s2.0-0027474051 (Pubitemid 23113469)
88. Nixon R. A., The calpains in aging and aging-related diseases. Ageing Research Reviews 2003 2 4 407 418 2-s2.0-0141762744 10.1016/S1568-1637(03)00029- 1 (Pubitemid 37159401)
89. Trinchese F., Fa' M., Liu S., Zhang H., Hidalgo A., Schmidt S. D., Yamaguchi H., Yoshii N., Mathews P. M., Nixon R. A., Arancio O., Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. The Journal of Clinical Investigation 2008 118 8 2796 2807 2-s2.0-48749089723 10.1172/JCI34254
90. Scheff S. W., Price D. A., Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiology of Aging 2003 24 8 1029 1046 2-s2.0-0345276568 10.1016/j.neurobiolaging.2003.08.002 (Pubitemid 37487881)
91. Amadoruge P. C., Barnham K. J., Alzheimer's disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling. International Journal of Alzheimer's Disease 2011 2011 9 2-s2.0-79955377011 10.4061/2011/542043 542043
92. Costa M., Cantoni O., de Mars M., Swartzendruber D. E., Toxic metals produce an S-phase-specific cell cycle block. Research Communications in Chemical Pathology and Pharmacology 1982 38 3 405 419 2-s2.0-0020407271 (Pubitemid 13204068)
93. Newhook R., Hirtle H., Byrne K., Meek M. E., Releases from copper smelters and refineries and zinc plants in Canada: human health exposure and risk characterization. Science of the Total Environment 2003 301 1-3 23 41 2-s2.0-0037213129 10.1016/S0048-9697(02)00229-2 (Pubitemid 35463212)
94. Arnal N., de Alaniz M. J., Marra C. A., Involvement of copper overload in human diseases. Metals in Biology Systems 2010 Research Signpost 1 28
95. Leung F. Y., Trace elements in parenteral micronutrition. Clinical Biochemistry 1995 28 6 561 566 2-s2.0-0028799047 10.1016/0009-9120(95)02007-8
96. Cuthbert J. A., Wilson's disease: a new gene and an animal model for an old disease. Journal of Investigative Medicine 1995 43 4 323 336 2-s2.0-0029353191
97. Notkola I.-L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., Nissinen A., Serum total cholesterol, apolipoprotein E ε 4 allele, and Alzheimer's disease. Neuroepidemiology 1998 17 1 14 20 2-s2.0-0031976318 10.1159/000026149 (Pubitemid 28153361)
98. Squitti R., Sparks D. L., Hoogenraad T. U., Brewer G. J., Copper status in Alzheimer's disease and other neurodegenerative disorders: genetics, mechanisms, neurophysiology, and therapies. International Journal of Alzheimer's Disease 2011 2011 2 2-s2.0-84855554472 10.4061/2011/903940 903940
99. Squitti R., Copper dysfunction in Alzheimer's disease: from meta-anlysis of biochemical studies to new insight into genetics. Journal of Trace Elements in Medicine and Biology 2012 26 2-3 93 96 10.1016/j.jtemb.2012.04.012